Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Kura Oncology: Strategische Einblicke zu Zypto/n auf der Jefferies Konferenz (Investing.com DE) +++ KURA ONCOLOGY Aktie +4,28%

Foren & Soziale Netzwerke zur SYNOPSYS Aktie

 >SYNOPSYS Aktienkurs 
336.95 EUR    +1.7%    (Tradegate)
Ask: 336.9 EUR / 16 Stück
Bid: 335.95 EUR / 200 Stück
Tagesumsatz: 499 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
SYNOPSYS Aktie über LYNX handeln
>SYNOPSYS Performance
1 Woche: -2,7%
1 Monat: -13,5%
3 Monate: -37,8%
6 Monate: -28,0%
1 Jahr: -32,9%
laufendes Jahr: -28,6%
>SYNOPSYS Aktie
Name:  SYNOPSYS INC. DL-,01
Land:  USA
Sektor:  Elektronik / Software
ISIN/ Wkn:  US8716071076 / 883703
Symbol/ Ticker:  SYP (Frankfurt) / SNPS (NASDAQ)
Kürzel:  FRA:SYP, ETR:SYP, SYP:GR, NASDAQ:SNPS
Index:  S&P500, Nasdaq100
Webseite:  https://www.synopsys.com/
Profil:  Synopsys Inc. is a leading provider of electronic ..
>Volltext..
Marktkapitalisierung:  62549.35 Mio. EUR
Unternehmenswert:  73536.04 Mio. EUR
Umsatz:  5547.89 Mio. EUR
EBITDA:  1504.13 Mio. EUR
Nettogewinn:  1727.14 Mio. EUR
Gewinn je Aktie:  11.15 EUR
Schulden:  13064.72 Mio. EUR
Liquide Mittel:  2184.19 Mio. EUR
Operativer Cashflow:  1244.05 Mio. EUR
Bargeldquote:  0.75
Umsatzwachstum:  -2.12%
Gewinnwachstum:  26.67%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  SYNOPSYS
Letzte Datenerhebung:  19.11.25
>SYNOPSYS Kennzahlen
Aktien/ Unternehmen:
Aktien: 185.75 Mio. St.
Frei handelbar: 99.14%
Rückkaufquote: -0.31%
Mitarbeiter: 20000
Umsatz/Mitarb.: 0.26 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 44.31%
Bewertung:
KGV: 29.67
KGV lG: 29.86
KUV: 9.7
KBV: 2.55
PEG-Ratio: 0.93
EV/EBITDA: 48.89
Rentabilität:
Bruttomarge: 75.18%
Gewinnmarge: 18.15%
Operative Marge: 20.79%
Managementeffizenz:
Gesamtkaprendite: 3.9%
Eigenkaprendite: 6.61%
>SYNOPSYS Peer Group

Es sind 435 Aktien bekannt.
 
11.09.25 - 20:33
Mizuho: buy Synopsys Inc. (Sharewise)
 
Kursziel: 512.88 €
11.09.25 - 15:27
SNPS - LONG Swing Entry Plan (TradingView)
 
NASDAQ:SNPS - LONG Swing Entry Plan E1: $414.00 – $400.00 → Open initial position targeting +8% from entry level. E2: $339.00 – $329.00 → If price dips further, average down with a second equal-sized entry. → New target becomes +8% from the average of Entry 1 and Entry 2. AD: $257.00 – $247.00 → If reached, enter with double the initial size to lower the overall cost basis. → Profit target remains +8% from the new average across all three entries. Risk Management: Stop Loss: Risk is capped at 12% below the average entry price (calculated across all executed positions including the Edit Zone). Position Sizing Approach: Entry 1: 1x Entry 2: 1x Edit Zone: 2x → Total exposure: 4x → Weighted average determines final TP and SL calculations. ______________________________________ Legal Disclaimer The information provided in this content is intended for educational and informational purposes only and does not constitute financial, investment, or legal advice or recommendations of any kind. The provider of t
11.09.25 - 15:18
SNPS (Synopsys, Inc.) — 2H TF | Long Setup (TradingView)
 
SNPS (Synopsys) experienced a parabolic run into $651 ATH, followed by a brutal selloff wiping out nearly $250 in value in a matter of days. This sharp capitulation was after the earnings shock and news impact. However the company fundamental and historical growth still very healthy! Currently, price is bouncing around $409–412, just above the major demand zone at $368–385. On the upside, clear supply zones sit at $605–616 and $639–651, which will act as hurdles for any recovery rally. Likely linked to earnings or lowered forward guidance (Synopsys is a leader in EDA software, highly sensitive to semiconductor cycle). Broader tech weakness and yield-driven selloff could have amplified losses. ? Trend & Structure: Primary Trend: Bullish (macro still intact from 2022 lows, but in deep correction) Short-Term: Bearish momentum Setup: Bounce from demand with potential retracement toward supply zones ? Key Supply/Demand Zones: Demand Zone (Buy Area): $368 – $385 Supply Zones (Sell Areas): $605 – $616
11.09.25 - 15:18
Morgan_Stanley: buy Synopsys Inc. (Sharewise)
 
Kursziel: 435.948 €
10.09.25 - 19:18
The_Goldman_Sachs_Gr: buy Synopsys Inc. (Sharewise)
 
Kursziel: 512.94 €
10.09.25 - 19:06
fenjal: buy Synopsys Inc. (Sharewise)
 
Kursziel: -
10.09.25 - 16:54
Wyckoff Stage #4 Markdown? (TradingView)
 
- NASDAQ:SNPS crashed on September 10, 2025 but I'm not interested in buying it yet. - Fundamentally it had a premium valuation which has gotten little compressed but I think it deserves to be punished more. - Monthly chart looks ugly and NASDAQ:SNPS is likely in a Wyckoff Stage #4 - Fundamentally, year | 2025 | 2026 | 2027 | 2028 EPS | 13.72 | 15.35 | 18.27 | 22.76 EPS% | 4.54% | 11.92% | 19.00% | 24.59% EPS is fluctuating from 4% to 24% in 2028. Considering average eps % to be 15%. Fair forward p/e would be 15 but I am willing to pay 20 forward p/e as the base case. Fair value: year | 2025 | 2026 | 2027 | 2028 EPS | 13.72 | 15.35 | 18.27 | 22.76 Price | $274 | $307 | $365 | $455 Bull Case ( forward p/e of 30 ) year | 2025 | 2026 | 2027 | 2028 EPS | 13.72 | 15.35 | 18.27 | 22.76 Price | $411 | $460 | $548 | $682 Bear Case ( forward p/e of 15 ) year | 2025 | 2026 | 2027 | 2028 EPS | 13.72 | 15.35 | 18.27 | 22.76 Price | $205 | $230 | $274 | $341
10.09.25 - 15:33
KeyCorp: buy Synopsys Inc. (Sharewise)
 
Kursziel: 504.391 €
25.07.25 - 15:03
Rosenblatt_Securitie: buy Synopsys Inc. (Sharewise)
 
Kursziel: 553.605 €
16.07.25 - 15:03
Bank_of_America_Co_: buy Synopsys Inc. (Sharewise)
 
Kursziel: 538.25 €
15.07.25 - 15:03
Needham___Company_LL: buy Synopsys Inc. (Sharewise)
 
Kursziel: 565.62 €
11.06.25 - 19:51
DerAlmanach100000: buy Synopsys Inc. (Sharewise)
 
Kursziel: -
29.05.25 - 19:48
Piper_Sandler: buy Synopsys Inc. (Sharewise)
 
Kursziel: 546.5505 €
20.05.25 - 15:33
KeyCorp: buy Synopsys Inc. (Sharewise)
 
Kursziel: 511.6925 €
15.04.25 - 16:03
KeyCorp: buy Synopsys Inc. (Sharewise)
 
Kursziel: 490.1205 €
15.04.25 - 15:33
Mizuho: buy Synopsys Inc. (Sharewise)
 
Kursziel: 529.86 €
12.03.25 - 23:27
fenjal: buy Synopsys Inc. (Sharewise)
 
Kursziel: -
27.02.25 - 19:18
Piper_Sandler: buy Synopsys Inc. (Sharewise)
 
Kursziel: 627.2065 €
25.02.25 - 15:48
Rosenblatt_Securitie: buy Synopsys Inc. (Sharewise)
 
Kursziel: 628.386 €
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Auf den Universitäten lernen die Wirtschaftsstudenten immer nur investieren. Fürs Schrumpfen haben die noch keinen Lehrstuhl. - Dr. Oskar Grünwald
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!